Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment - PubMed (original) (raw)
Review
Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment
Suzanne Craft. Curr Alzheimer Res. 2007 Apr.
Abstract
Insulin modulates cognition and other aspects of normal brain function. Insulin resistance is characterized by chronic peripheral insulin elevations, and it is accompanied by reduced brain insulin levels and insulin activity. Obesity, type 2 diabetes mellitus and hypertension are strongly associated with insulin resistance. In addition, insulin resistance increases the risk of age-related memory impairment and Alzheimer's disease. Possible mechanisms through which these risks are increased include the effects of peripheral hyperinsulinemia on memory, CNS inflammation, and regulation of the beta-amyloid peptide. We have shown that raising plasma insulin in humans to levels that characterize patients with insulin resistance increases the levels of Abeta and inflammatory agents in brain. These convergent effects may impair memory and induce AD pathology. Therapeutic strategies focused on preventing or correcting insulin abnormalities may thus benefit a subset of adults with age-related memory impairment and AD.
Similar articles
- Insulin resistance syndrome and Alzheimer's disease: age- and obesity-related effects on memory, amyloid, and inflammation.
Craft S. Craft S. Neurobiol Aging. 2005 Dec;26 Suppl 1:65-9. doi: 10.1016/j.neurobiolaging.2005.08.021. Epub 2005 Nov 2. Neurobiol Aging. 2005. PMID: 16266773 Review. - Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications.
Craft S. Craft S. Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):298-301. doi: 10.1097/01.wad.0000213866.86934.7e. Alzheimer Dis Assoc Disord. 2006. PMID: 17132977 Review. - Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
Wakabayashi T, Yamaguchi K, Matsui K, Sano T, Kubota T, Hashimoto T, Mano A, Yamada K, Matsuo Y, Kubota N, Kadowaki T, Iwatsubo T. Wakabayashi T, et al. Mol Neurodegener. 2019 Apr 12;14(1):15. doi: 10.1186/s13024-019-0315-7. Mol Neurodegener. 2019. PMID: 30975165 Free PMC article. - Insulin resistance and Alzheimer's disease: molecular links & clinical implications.
Neumann KF, Rojo L, Navarrete LP, Farías G, Reyes P, Maccioni RB. Neumann KF, et al. Curr Alzheimer Res. 2008 Oct;5(5):438-47. doi: 10.2174/156720508785908919. Curr Alzheimer Res. 2008. PMID: 18855585 - The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.
Watson GS, Craft S. Watson GS, et al. CNS Drugs. 2003;17(1):27-45. doi: 10.2165/00023210-200317010-00003. CNS Drugs. 2003. PMID: 12467491 Review.
Cited by
- Obesity, insulin resistance, and Alzheimer's disease.
Hildreth KL, Van Pelt RE, Schwartz RS. Hildreth KL, et al. Obesity (Silver Spring). 2012 Aug;20(8):1549-57. doi: 10.1038/oby.2012.19. Epub 2012 Feb 7. Obesity (Silver Spring). 2012. PMID: 22310232 Free PMC article. Review. No abstract available. - Targeting Alzheimer's Disease Neuro-Metabolic Dysfunction with a Small Molecule Nuclear Receptor Agonist (T3D-959) Reverses Disease Pathologies.
Tong M, Dominguez C, Didsbury J, de la Monte SM. Tong M, et al. J Alzheimers Dis Parkinsonism. 2016 Jun;6(3):238. doi: 10.4172/2161-0460.1000238. Epub 2016 Jun 3. J Alzheimers Dis Parkinsonism. 2016. PMID: 27525190 Free PMC article. - Antidiabetic and Neuroprotective Effect of the N-Butanol Extract of Fragaria nilgerrensis Schlecht. in STZ-Induced Diabetic Mice.
Gao L, Wang X, Lin Z, Song N, Liu X, Chi X, Shao T. Gao L, et al. Evid Based Complement Alternat Med. 2018 Sep 4;2018:6938370. doi: 10.1155/2018/6938370. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 30254687 Free PMC article. - The link between iron, metabolic syndrome, and Alzheimer's disease.
Grünblatt E, Bartl J, Riederer P. Grünblatt E, et al. J Neural Transm (Vienna). 2011 Mar;118(3):371-9. doi: 10.1007/s00702-010-0426-3. Epub 2010 Jun 17. J Neural Transm (Vienna). 2011. PMID: 20556444 Review. - Potential synaptic plasticity-based Shenzhiling oral liquid for a SAD Mouse Model.
Wang Y, Wang P, Chen F, Lulu M, Huang S, Liu Z. Wang Y, et al. Brain Behav. 2019 Sep;9(9):e01385. doi: 10.1002/brb3.1385. Epub 2019 Aug 20. Brain Behav. 2019. PMID: 31429527 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical